RetinAI Medical and IbtiCare win the second stage of Venture Kick
14.07.2017
The two startup projects and their teams win CHF 20’000 each. They are now getting ready for the program’s final where they might win CHF 130’000 in total. Learn more about the winners and their technology.
 Carlos Ciller, Stefanos Apostolopoulos and Sandro De Zanet from RetinAI
|
 |
 Soheil Hasanzadeh and Sami Rtimi from IbtiCare
|
|
RetinAI Medical, (UNIL) - Medtech: Empowering eye care professionals and patients through artificial intelligence
RetinAI develops software solutions to facilitate the analysis of medical images of the eye using artificial intelligence. The company uses the latest machine learning (deep learning) and medical image processing techniques to develop a software platform that enables the automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography.
These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
RetinAI’s CEO, Carlos Ciller, travelled to Boston in June 2017 to meet investors and assess the market potential of his innovation on the US market, with the venture leaders Life Science program.
IbtiCare (EPFL) - Medtech: Innovative antibacterial technology based on modified Physical Vapor Deposition
IbtiCare has invented an innovative antibacterial technology based on Physical Vapor Deposition (PVD). By this cutting edge technology and procedure, all the potential surfaces for bacteria contamination can become self-sterilizing.
According to the clinical trials ran at the University Hospital of Lausanne (CHUV), the antibacterial coating is effective to kill multi-drug resistant bacteria. Thanks to the IbtiCare’s developed PVD technology, the antibacterial nanoparticulate coatings can be deposited on surfaces of complex 3D shapes and also on non-heat resistance surfaces without destroying their mechanical standing.
IbtiCare’s antibacterial coating can be applied on many surfaces e.g. medical textile or complex shape medical devices. The deposited materials are strongly adhesive to the substrate and shows high uniformity. They cannot be released and pollute the environment and are not toxic for human body, compared to the current silver-nanoparticles dispersion products.